Arihant Capital said Lenskart is poised to sustain its cost-efficient growth by leveraging a centralized…
Rubicon Research IPO Allotment Status, Subscription Details, Listing Date 2025
The Rubicon Research IPO allotment is expected to be finalised on Tuesday, October 14, 2025.
You can check the final allotment on the NSE, BSE, and MUFG Intime India websites.
IPO Subscription
The IPO got a strong response from investors.
Price per share: ₹461 to ₹485
Total subscription: 103.90 times
Total bids: 1,70,96,80,620 shares
Shares on offer: 1,64,55,670 shares
Category-wise subscription:
Qualified Institutional Buyers: 130.26 times
Non-Institutional Investors: 97.61 times
Retail Investors: 35.47 times
IPO Details
The IPO aimed to raise ₹1,377.50 crore:
New shares: ₹500 crore
Sale by promoter: ₹877.50 crore
The money will be used for:
Paying loans
Buying other companies
General business purposes
About Rubicon Research
Rubicon Research is a pharmaceutical company.
It focuses on research and development (R&D).
It makes speciality products and drug-device combinations for regulated markets.
Related Articles
The opinions and investment advice provided by experts on ipogmp.org are solely their own and do not reflect the views of the website or its management. Ipogmp.org recommends that users consult with certified professionals before making any investment decisions. *Please note that advisory services mentioned on Ipogmp.org are not currently operational and are proposed services awaiting SEBI registration.Related Posts
This Post Has 0 Comments